Neurobiology of animal models of attention-deficit hyperactivity disorder

被引:98
|
作者
Russell, Vivienne Ann [1 ]
机构
[1] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, ZA-7925 Observatory, South Africa
基金
英国医学研究理事会;
关键词
norepinephrine; dopamine; attention; hyperactivity; SHR; thyroid hormone;
D O I
10.1016/j.jneumeth.2006.12.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) is a heterogeneous, highly heritable, disorder resulting from complex gene-gene and gene-environment interactions. The defining symptoms of hyperactivity, impulsivity and impaired sustained attention are not unique to ADHD. It is therefore not surprising that animals with distinctly different neural defects model the behavioural characteristics of the disorder. Consistent with ADHD being a developmental disorder, animal models are either genetic (spontaneously hypertensive rats (SHR), dopamine transporter (DAT) knock-out mice, SNAP-25 mutant mice, mice expressing a mutant thyroid receptor) or have suffered an insult to the central nervous system during the early stages of development (anoxia, 6-hydroxydopamine). It appears that neural transmission is impaired by either direct disruption of dopaminergic transmission or a more general impairment of neurotransmission that gives rise to compensatory changes in monoaminergic systems that are not sufficient to completely normalize neural function. In general, results obtained with animal studies suggest that dopamine neurons are functionally impaired. However, evidence obtained from some animal models suggests that the noradrenergic and serotonergic neurotransmitter systems may be the target of drugs that ameliorate ADHD symptoms. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:185 / 198
页数:14
相关论文
共 50 条
  • [21] Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder
    van der Kooij, Michael A.
    Glennon, Jeffrey C.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (04): : 597 - 618
  • [22] Attention-Deficit/Hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology
    Spencer, Thomas J.
    Biederman, Joseph
    Mick, Eric
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2007, 32 (06) : 631 - 642
  • [23] Attention-deficit/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology
    Spencer, Thomas J.
    Biederman, Joseph
    Mick, Eric
    AMBULATORY PEDIATRICS, 2007, 7 (01) : 73 - 81
  • [24] ADVANCES IN THE NEUROBIOLOGY OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND RELATED DISORDERS
    Biederman, Joseph
    McGough, James J.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S272 - S272
  • [25] Rodent models of attention-deficit/hyperactivity disorder
    Sagvolden, T
    Russell, VA
    Aase, H
    Johansen, EB
    Farshbaf, M
    BIOLOGICAL PSYCHIATRY, 2005, 57 (11) : 1239 - 1247
  • [27] Neurobiology of attention deficit/hyperactivity disorder
    Purper-Ouakil, Diane
    Lepagnol-Bestel, Aude-Marie
    Grosbellet, Edith
    Gorwood, Philip
    Simonneau, Michel
    M S-MEDECINE SCIENCES, 2010, 26 (05): : 487 - 496
  • [28] ATTENTION DEFICIT HYPERACTIVITY DISORDER AND NEUROBIOLOGY
    Bellgrove, M.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 94 - 94
  • [29] Neurobiology of Attention Deficit/Hyperactivity Disorder
    Purper-Ouakil, Diane
    Ramoz, Nicolas
    Lepagnol-Bestel, Aude-Marie
    Gorwood, Philip
    Simonneau, Michel
    PEDIATRIC RESEARCH, 2011, 69 (05) : 69R - 76R
  • [30] The neurobiology of attention deficit/hyperactivity disorder
    Curatolo, Paolo
    Paloscia, Claudio
    D'Agati, Elisa
    Moavero, Romina
    Pasini, Augusto
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (04) : 299 - 304